.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This European propensity-matched study compared minimally invasive distal pancreatectomy with open surgery for pancreatic ductal adenocarcinoma. After adjustment for baseline differences, minimally invasive surgery was associated with several short-term advantages while maintaining broadly comparable oncological outcomes in appropriately selected patients. The findings support the feasibility of laparoscopy in distal pancreatic resection when performed in experienced centers with careful patient selection. For HPB surgeons, the important point is that minimally invasive pancreatic surgery should not be assessed only by whether an operation can be completed laparoscopically. Key outcomes include margin status, lymph-node harvest, postoperative pancreatic fistula, length of stay, morbidity and long-term cancer control. The study therefore supports adoption within structured HPB programs rather than indiscriminate expansion. Surgeons should also recognize that open conversion remains an acceptable safety decision when anatomy, tumor involvement or bleeding makes minimally invasive continuation unsafe. The evidence helps define minimally invasive distal pancreatectomy as a credible option within expert multidisciplinary pancreatic surgery services.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This European propensity-matched study compared minimally invasive distal pancreatectomy with open surgery for pancreatic ductal adenocarcinoma. After adjustment for baseline differences, minimally invasive surgery was associated with several short-term advantages while maintaining broadly comparable oncological outcomes in appropriately selected patients. The findings support the feasibility of laparoscopy in distal pancreatic resection when performed in experienced centers with careful patient selection. For HPB surgeons, the important point is that minimally invasive pancreatic surgery should not be assessed only by whether an operation can be completed laparoscopically. Key outcomes include margin status, lymph-node harvest, postoperative pancreatic fistula, length of stay, morbidity and long-term cancer control. The study therefore supports adoption within structured HPB programs rather than indiscriminate expansion. Surgeons should also recognize that open conversion remains an acceptable safety decision when anatomy, tumor involvement or bleeding makes minimally invasive continuation unsafe. The evidence helps define minimally invasive distal pancreatectomy as a credible option within expert multidisciplinary pancreatic surgery services.
4 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
